PAIYY (Aesthetic Medical International Holdings Group) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aesthetic Medical International Holdings Group 5-Year Yield-on-Cost %?

Aesthetic Medical International Holdings Group PAIYY 5-Year Yield-on-Cost % is 0.00 as of Jul. 22, 2026. The stock has 5 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Aesthetic Medical International Holdings Group ranks worse than 361010.47% on this metric.

Aesthetic Medical International Holdings Group's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for Aesthetic Medical International Holdings Group's 5-Year Yield-on-Cost % or its related term are showing as below:



PAIYY's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.93
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Aesthetic Medical International Holdings Group  (OTCPK:PAIYY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Aesthetic Medical International Holdings Group 5-Year Yield-on-Cost % Related Terms


PAIYY vs GRST, BACK, FCHS: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, Aesthetic Medical International Holdings Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aesthetic Medical International Holdings Group 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aesthetic Medical International Holdings Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Aesthetic Medical International Holdings Group's 5-Year Yield-on-Cost % falls into.



Aesthetic Medical International Holdings Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Aesthetic Medical International Holdings Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Aesthetic Medical International Holdings Group (PAIYY) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Aesthetic Medical International Holdings Group and its competitors. According to the industry distribution chart, Aesthetic Medical International Holdings Group ranks #999999 out of 277 companies in the Healthcare Providers & Services industry.
Is Aesthetic Medical International Holdings Group's 5-Year Yield-on-Cost % too high?
Aesthetic Medical International Holdings Group's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Aesthetic Medical International Holdings Group ranks #999999 out of 277 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Aesthetic Medical International Holdings Group's 5-Year Yield-on-Cost % compare to GRST and BACK?
According to the Healthcare Providers & Services industry distribution chart, Aesthetic Medical International Holdings Group ranks #999999 out of 277 companies for 5-Year Yield-on-Cost %. This places Aesthetic Medical International Holdings Group in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Aesthetic Medical International Holdings Group and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aesthetic Medical International Holdings Group's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aesthetic Medical International Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Aesthetic Medical International Holdings Group (PAIYY) is currently considered Possible Value Trap. The stock's GF Value™ is $0.27, compared to a current price of $0.02 — trading 92.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Aesthetic Medical International Holdings Group (PAIYY), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aesthetic Medical International Holdings Group Business Description

Address 1122 Nanshan Boulevard, Nanshan District, Guangdong Province, Shenzhen, CHN, 518052
Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from three service offerings: non-surgical aesthetic medical services, surgical aesthetic medical services, general healthcare services, and other aesthetic medical services in the People's Republic of China. The company derives a majority of its revenue from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.